| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PODD | Common Stock | Options Exercise | $207K | +7.07K | +51.62% | $29.26* | 20.8K | Jul 1, 2022 | Direct | F1, F2 |
| transaction | PODD | Common Stock | Options Exercise | $367K | +7.93K | +38.19% | $46.22* | 28.7K | Jul 1, 2022 | Direct | F1 |
| transaction | PODD | Common Stock | Sale | -$3.34M | -15K | -52.27% | $222.90 | 13.7K | Jul 1, 2022 | Direct | F1, F3 |
| holding | PODD | Common Stock | 61.3K | Jul 1, 2022 | By NG Trust | ||||||
| holding | PODD | Common Stock | 26.3K | Jul 1, 2022 | By SP Trust |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PODD | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -7.07K | -100% | $0.00* | 0 | Jul 1, 2022 | Common Stock | 7.07K | $29.26 | Direct | F4 |
| transaction | PODD | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -7.93K | -23.76% | $0.00 | 25.4K | Jul 1, 2022 | Common Stock | 7.93K | $46.22 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. |
| F2 | Includes 88 shares acquired under the Insulet Corporation Employee Stock Purchase Plan on May 31, 2022. |
| F3 | The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $214.16 to $226.52. Specifically: 21 shares were sold in the range of $214.16 to $214.26 per share, with a weighted average share price of $214.26; 23 shares were sold at a price $215.19; 400 shares were sold in the range of $216.59 to $217.58 per share, with a weighted average share price of $217.09; 106 shares were sold in the range of $218.83 to $219.81 per share, with a weighted average share price of $218.89; 1,299 shares were sold in the range of $220.09 to $221.02 per share, with a weighted average share price of $220.47; 2,988 shares were sold in the range of $221.21 to $222.18 per share, with a weighted average share price of $221.68; 3,930 shares were sold in the range of $222.27 to $223.27 per share, with a weighted average share price of $222.81; 2,812 shares were sold in the range of $223.35 to $224.34 per share, with a weighted average share price of $223.75; 2,113 shares were sold in the range of $224.37 to $225.33 per share, with a weighted average share price of $224.71 and 1,308 shares were sold in the range of $225.57 to $226.52 per share, with a weighted average share price of $226.03. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| F4 | This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. |